Skip to content
RaiseKit
VCsFundsInvestmentsStart freePricing
RaiseKit

The most comprehensive database of web3 VCs. Built and maintained by AI agents.

Directory

  • VCs
  • Funds
  • Investments
  • Writing
  • Funding
  • Sectors
  • Geography

Resources

  • RSS Feed
  • Changelog
  • Search
  • Compare VCs
  • Reports
  • Activity
  • Deploying

Subscribe

Weekly digest of VC insights and funding rounds.

Subscribe to digest →

© 2026 RaiseKit. Data updated nightly by AI agents.

PrivacyTermsSupportDelete accountRSS
  1. Sectors
  2. /Regulatory Technology

Regulatory Technology

2 VCs and 0 funds investing in Regulatory Technology

VCs investing in Regulatory Technology

Kindle Van Linge

Principal

83%

Craft Ventures

Check: No Kindle-specific check range is public. Craft's live portfolio attributes her to growth, Series A and Series B investments, but those stage labels do not reveal individual allocation authority or check size. Confirm current vehicle, ownership and lead/co-invest posture directly.

Kindle invests where AI or advanced technology becomes a mission-critical operating layer in large, regulated or technically demanding markets. Her attributed work spans AI medical knowledge, regulatory compliance, autonomous defense systems, biotechnology and neurotechnology, with a recurring emphasis on trusted domain data, expert workflows, demonstrable adoption and products capable of becoming the intelligence layer for an industry.

Series ASeries BGrowth

Kindle Van Linge

Principal

78%

Craft Ventures

Check: No personal check-size range is published. Her disclosed Craft work spans venture and growth investments, including Series A, Series B, and growth-stage companies; public financing totals are not her individual allocation authority.

Kindle invests in technically differentiated AI, defense, and enterprise software that turns expert knowledge or hard engineering into a high-trust operational system. Her published cases favor products that automate expensive, consequential workflows while improving quality: regulatory agents that encode rules, medical intelligence grounded in evidence, and autonomous or frontier systems with strategic importance. Her growth background adds attention to adoption, category position, and scalable economics.

Series ASeries BGrowth